Compile Data Set for Download or QSAR
Report error Found 255 of affinity data for UniProtKB/TrEMBL: P19174
LigandPNGBDBM50535744(CHEMBL4536333)
Affinity DataEC50:  2.50E+4nMAssay Description:Binding affinity to human full length Myc-tagged PLCgamma1 transfected in HEK293T cells by pull down assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/28/2021
Entry Details Article
PubMed
LigandPNGBDBM50037076(CHEMBL3355737)
Affinity DataIC50: 180nMAssay Description:Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
LigandPNGBDBM50037063(CHEMBL3355726)
Affinity DataIC50: 540nMAssay Description:Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
LigandPNGBDBM81141(US9695200, 6)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM87738(US9695200, 11)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88535(US9695200, 20)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88551(US9695200, 22)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88562(US9695200, 24)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88653(US9695200, 25)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88670(US9695200, 26)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98760(US9695200, 28)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98786(US9695200, 32)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98821(US9695200, 41)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99737(US9695200, 46)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99786(US9695200, 49)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99790(US9695200, 50)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99847(US9695200, 57)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99857(US9695200, 59)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM100765(US9695200, 61)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM100784(US9695200, 62)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM100881(US9695200, 67)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM103397(US9695200, 72)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM107352(US9695200, 74)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM107952(US9695200, 76)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM108039(US9695200, 80)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM108388(US9695200, 89)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM108763(US9695200, 91)
Affinity DataIC50: 1.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM84007(SMR001307271 | Cefiximum [Latin] | cid_5362065 | M...)
Affinity DataIC50: 1.21E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM34905(1,6-dimethyl-3-propyl-pyrimido[5,4-e][1,2,4]triazi...)
Affinity DataIC50: 1.51E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM52817(2-[(5Z)-5-[(E)-3-(furan-2-yl)prop-2-enylidene]-4-o...)
Affinity DataIC50: 1.51E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM114297(dimethyl 2-[(3R,6S)-1-acetyl-6-[(4-methylphenyl)su...)
Affinity DataIC50: 2.03E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM18136(alpha, beta-methyleneadenosine 5 -diphosphate | ci...)
Affinity DataIC50: 2.20E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
LigandPNGBDBM50037060(CHEMBL3355311)
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of PLC gamma-1 phosphorylation in human Jurkat T cells after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
Target1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [1-999,I813T](Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM114292(2-(2-cyano-3-pyridinyl)-2-methylpropanoic acid met...)
Affinity DataIC50: 2.70E+3nMAssay Description:Source (MLPCN Center Name): The Scripps Research Institute Molecular Screening Center (SRIMSC) Center Affiliation: The Scripps Research Institute Ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2014
Entry Details
PCBioAssay
LigandPNGBDBM81238(US9695200, 8)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM87754(US9695200, 12)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88537(US9695200, 21)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM88558(US9695200, 23)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98772(US9695200, 29)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98779(US9695200, 30)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98793(US9695200, 33)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98807(US9695200, 37)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98813(US9695200, 39)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98848(US9695200, 42)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98850(US9695200, 43)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM98918(US9695200, 44)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99728(US9695200, 45)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99779(US9695200, 48)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99793(US9695200, 51)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

LigandPNGBDBM99799(US9695200, 54)
Affinity DataIC50: 3.00E+3nMT: 2°CAssay Description:Compounds were serially diluted into DMSO, and then into media to concentrations 10× that of the final assay concentration. Compounds were then added...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 255 total ) | Next | Last >>
Jump to: